DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Response to Arguments
Applicant's arguments filed 8/18/2026 have been fully considered. Regarding the amendments to the drawings, the amendments to figs. 1 and 2 are acceptable, but other issues remain as discussed further below.
Claim 1 was amended to incorporate allowable subject matter and overcomes the previous rejection under 35 U.S.C. 102(a)(1), however, there are new issues of indefiniteness as discussed further below.
Regarding claim 16, applicant argues claim 16 was amended to incorporate the allowable subject matter of claim 19. The previous examiner indicated that claim 19 would be allowable if incorporated into the base claim, but claim 19 was dependent from claim 9 not 16. The previous examiner noted that for examination, claims 17-19 were understood to depend from claim 16 rather than claim 9, therefore it appears applicant was correct in adding claim 19 to claim 16 based on the previous examiner’s comments. However, upon further search and consideration, claims 16-18 are rejected under 35 U.S.C. 102(a)(1) as discussed below.
Drawings
The drawings are objected to as failing to comply with 37 CFR 1.84(p)(4) because reference character “110” has been used to designate both a shoe interior and a foot of the patient. In figs. 3A-3C, 110 is directed to a foot of the patient, but in fig.1 and par.38 of the specification, 110 is the shoe interior. It appears reference number 110 in figs. 3A-3C is supposed to be reference character 120. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance.
Claim Objections
Claims 1, 6, and 9 are objected to because of the following informalities:
In claim 1, line 12 “the moldable material” should recite --the moldable material component-- for consistency with previous language.
In claim 1, line 17, “the enclosure system” should recite --the adjustable enclosure system-- for consistency with previous language.
In claim 6, line 1 “the moldable material” should recite --the moldable material component-- for consistency with previous language.
In claim 9, line 3 “the cap component” should recite --the prosthetic cap component-- for consistency with previous language.
In claim 9, line 4 “the latitudinal axis” is believed to be in error for --a latitudinal axis-- since the latitudinal axis has not been previously recited.
Appropriate correction is required.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1, 6, 9, and 16-18 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Regarding claim 1, lines 5-7 recite “the moldable material component comprises two parts that are mixed together to form a final shape capable of being formed and contoured…” which is unclear. How can a final shape be formed and contoured? What makes the shape “final” if it is then contoured? The “final shape” is further unclear because lines 8-9 recite “the moldable material component can then be cured”. Does this mean the final shape is not a cured shape? Please clarify.
Claim 16, line 4 recites “to generally replace any anatomical features normally present on a footplate”. The scope of “to generally replace” and “normally present on a footplate” are unclear and the specification does not provide a standard for ascertaining the requisite degree of “generally replace” and “normally present”.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claims 16-18 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Jackson US 3,968,577 (hereafter referred to as Jackson; cited in IDS).
Regarding claim 16, Jackson discloses a customized orthotic device, the device comprising: a moldable material 22 capable of curing to a final shape (figs.1-8; col.3, lines 58-64), and a footplate 24 (figs. 3-4), wherein the moldable material is capable of placement on the footplate to generally replace any anatomical features normally present on a footplate, wherein the footplate includes a hollow component 26 for molding the moldable material around, wherein the hollow component allows for the use of less moldable material during construction (figs. 3-4; edge 26 forms a hollow component that retains the moldable material during application and molding and therefore allows for the use of less moldable material during construction).
Regarding claims 17 and 18, see the silicone rubber mixture having a curing agent in col.3, lines 58-68. A mixture has at least two parts.
Allowable Subject Matter
Claims 1, 6, and 9 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action.
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. McCroskey, Sr. US 3,981,037 and Coomer US 5,647,147 each disclose a customized orthotic device comprising a moldable material capable of curing to a final shape and a footplate including a hollow component.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to MEGAN Y WOLF whose telephone number is (571)270-3071. The examiner can normally be reached Mon-Fri 8am-2pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Melanie Tyson can be reached at (571)272-9062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/MEGAN Y WOLF/
Primary Examiner, Art Unit 3774